Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Tabarin

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|May 4, 2012
Combination chemotherapy in advanced adrenocortical carcinomaMartin Fassnacht, Massimo Terzolo, Bruno Allolio, et al.
European Journal of Endocrinology|July 15, 2011
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomasMaria A Tichomirowa, Anne Barlier, Adrian F Daly, et al.
Endocrine-Related Cancer|February 1, 2012
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindredsMaria A Tichomirowa, Misu Lee, Anne Barlier, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2020
Response to Letter to the Editor: "CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma"Letizia Canu, Janna A W Van Hemert, Michiel Kerstens, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
Annales D'Endocrinologie|February 22, 2022
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndromeAntoine Tabarin, Guillaume Assié, Pascal Barat, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesisVasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
Annals of Internal Medicine|January 3, 2022
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter StudyAlessandro Prete, Anuradhaa Subramanian, Irina Bancos, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|May 4, 2012
Combination chemotherapy in advanced adrenocortical carcinomaMartin Fassnacht, Massimo Terzolo, Bruno Allolio, et al.
European Journal of Endocrinology|July 15, 2011
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomasMaria A Tichomirowa, Anne Barlier, Adrian F Daly, et al.
Endocrine-Related Cancer|February 1, 2012
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindredsMaria A Tichomirowa, Misu Lee, Anne Barlier, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2020
Response to Letter to the Editor: "CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma"Letizia Canu, Janna A W Van Hemert, Michiel Kerstens, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
Annales D'Endocrinologie|February 22, 2022
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndromeAntoine Tabarin, Guillaume Assié, Pascal Barat, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesisVasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
Annals of Internal Medicine|January 3, 2022
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter StudyAlessandro Prete, Anuradhaa Subramanian, Irina Bancos, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 19